These scientific works converge in addressing chemokine receptor modulation as a possibility for ALS treatment, focusing on the antagonism of certain isoforms.The three-dimensional structures of CXCR2, CXCR3, and CXCR4 are represented in Figure 7. Here, CXCR2 is linked to amyotrophic lateral sclerosis.